Biomedical Engineering Reference
In-Depth Information
Seyler I, Appel M, Devissaguet J Ph, Legrand P and Barratt G (1997), 'Modulation of nitric oxide
production in RAW 264.7 cells by Transforming Growth Factor-b and Interleukin-10',
J Leukoc Biol
, 62, 374-380.
Seyler I, Appel M, Devissaguet J Ph, Legrand P and Barratt G (1999), 'Macrophage activation by
a lipophilic derivative of muramyldipeptide within nanocapsules: investigation of the mecha-
nism of drug delivery',
J Nanoparticle Res
, 1, 91-97.
Shen X C, Zhou J, Liu X, Wu J, Qu F, Zhang Z L Pang D W, Quéléver G, Zhang C C and Peng
L (2007), 'Importance of size-to-charge ratio in construction of stable and uniform nanoscale
RNA/dendrimer complexes',
Org Biomol Chem,
5, 3674-3681.
Singh M, Ugozzoli M, Briones M, Kazzaz J, Soenawan E and O'Hagan D T (2003), 'The effect
of CTAB concentration in cationic PLG microparticles on DNA adsorption and
in vivo
perfor-
mance',
Pharm Res,
20, 247-251.
Swanson J A and Watts C (1995), 'Macropinocytosis',
Trends Cell Biol
, 5, 424-428.
Szebeni J (1998), 'The interaction of liposomes with the complement system',
Crit Rev Ther Drug
Carrier Syst
, 15, 57-88.
Szoka FC Jr (1990), 'The future of liposomal drug delivery',
Biotechnol Appl Biochem
, 12,
496-500.
Tabata Y and Ikada Y (1988), 'Effect of the size and surface charge of polymer microspheres on
their phagocytosis by macrophage',
Biomaterials
, 9, 356-362.
Tondelli L, Ricca A, Laus M, Lelli M and Citro G (1998), 'Highly efficient cellular uptake of
c-myb antisense oligonucleotides through specifically designed polymeric nanospheres',
Nucleic Acids Res,
26, 5425-5431.
Toub N, Angiari C, Eboue D, Fattal E, Tenu J P, Le Doan T and Couvreur P (2005), 'Cellular fate
of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate)',
J Control
Rel,
106, 209-213.
Toub N, Bertrand J R, Malvy C, Fattal E and Couvreur P (2006), 'Antisense oligonucleotide
nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model',
Oligonucleotides,
16, 158-168.
Turánek J, Ledvina M, Kasná A, Vacek A, Hríbalova V, Krejcí J and Miller A D (2006),
'Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants',
Vaccine
, 24 Suppl 2:S90-S91
Urban-Klein B, Werth S, Abuharbeid S, Czubayko F and Aigner A (2005), 'RNAi-mediated gene-
targeting through systemic application of polyethylenimine (PEI)-complexed siRNA
in vivo
',
Gene Ther,
12, 461-466.
van Broekhoven C L, Parish C R, Demangel C, Britton W J and Altin J G (2004), 'Targeting
dendritic cells with antigen-containing liposomes: a highly effective procedure for induction
of antitumor immunity and for tumor immunotherapy',
Cancer Res
, 64, 4357-4365.
Vauthier C and Bouchemal K (2009), 'Methods for the preparation and manufacture of polymeric
nanoparticles',
Pharm Res
, 26, 1025-1058.
Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux J C and Benoit J P (2006), 'Evaluation
of pegylated lipid nanocapsules versus complement system activation and macrophage
uptake',
J Biomed Mater Res A
, 78, 620-628.
Vyas, S P, Katare Y K, Mishra V and Sihorkar V (2000), 'Ligand directed macrophage targeting
of amphotericin B loaded liposomes',
Int J Pharm
, 210, 1-14.
Waite C L, Sparks S M, Uhrich K E and Roth C M (2009), 'Acetylation of PAMAM dendrimers
for cellular delivery of siRNA',
BMC Biotechnol
, 9, 38.
Weyermann J, Lochmann D, Georgens C and Zimmer A (2005), 'Albumin-protamine- oligonucle-
otide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect',
Eur
J Pharm Biopharm,
59, 431-438.
Wissing S A, Kayser O and Müller R H (2004), 'Solid lipid nanoparticles for parenteral drug
delivery',
Adv Drug Deliv Rev
, 56, 1257-1272.
Woodle M C (1998), 'Controlling liposome blood clearance by surface-grafted polymers',
Adv
Drug Deliv Rev,
32, 139-152.
Xu Y and Szoka FC Jr (1996), 'Mechanism of DNA release from cationic liposome/DNA complexes
used in cell transfection',
Biochemistry
, 35, 5616-5623.
Search WWH ::
Custom Search